StockData
ResMed Inc logo

ResMed Inc

RMDNYSESurgical & Medical Instruments & ApparatusFiscal year ends June 30Also trades as RSMDF
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 21/3011% below fair value
$242.61+4.76 (+2.00%)

Close on Nov 18, 2026Market cap $34.12BP/E 22.1Yield 0.99%

ResMed Global Devices by Quarter

Global Devices — Share of Quarterly Consolidated Revenue (Legacy through FY2026Q3, %) (%)

Periods

ResMed Global Devices: 51.0% in Q3 FY26, down 1.0 pts from a year earlier. That is the lowest of the 16 quarters on record here.

Latest, Q3 FY26
51.0%
Period ended Mar 31, 2026 (CQ1 2026)
Change on a year earlier
-1.0 pts
52.0% in Q3 FY25
History
16 quarters
Since Q4 FY22
Sources
16
Documents cited below

Where the Q3 FY26 figure comes from

“Q3 FY26 financial results YoY Revenue Trajectory Revenue by Revenue Segment by and Region Business ($ in millions) Revenue % by Segment $1,431.4 12% Devices Masks and other $1,291.7 51% 37% RCS Revenue % by Region U.S., Canada, & 12% Latin America Europe, Asia, & 31% Other 57% RCS (U.S. & Q3 FY25 Q3 FY26 Germany) Note: Data as of March 31, 2026. Resmed’s fiscal year end is”

Source: ResMed Q3 FY2026 Earnings Presentation (2026-04-30) ↗

Reported in ResMed Quarterly Earnings Presentations (Quarterly Business Mix Slide).

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedGlobal Devices — Share of Quarterly Consolidated Revenue (Legacy through FY2026Q3, %) (%)Year on yearSource
Q3 FY26CQ1 2026Mar 31, 202651.0%-1.0 ptsResMed Q3 FY2026 Earnings Presentation (2026-04-30) ↗
Q2 FY26CQ4 2025Dec 31, 202551.0%-1.0 ptsResMed Q2 FY2026 Earnings Presentation (2026-01-29) ↗
Q1 FY26CQ3 2025Sep 30, 202551.0%0.0 ptsResMed Q1 FY2026 Earnings Presentation (2025-10-30) ↗
Q4 FY25CQ2 2025Jun 30, 202552.0%0.0 ptsResMed Q4 FY2025 Earnings Presentation (2025-07-31) ↗
Q3 FY25CQ1 2025Mar 31, 202552.0%-1.0 ptsResMed Q3 FY2025 Earnings Presentation (2025-04-23) ↗
Q2 FY25CQ4 2024Dec 31, 202452.0%0.0 ptsResMed Q2 FY2025 Earnings Presentation (2025-01-30) ↗
Q1 FY25CQ3 2024Sep 30, 202451.0%0.0 ptsResMed Q1 FY2025 Earnings Presentation (2024-10-24) ↗
Q4 FY24CQ2 2024Jun 30, 202452.0%-2.0 ptsResMed Q4 FY2024 Earnings Presentation (2024-08-01) ↗
Q3 FY24CQ1 2024Mar 31, 202453.0%-2.0 ptsResMed Q3 FY2024 Earnings Presentation (2024-04-25) ↗
Q2 FY24CQ4 2023Dec 31, 202352.0%-1.0 ptsResMed Q2 FY2024 Earnings Presentation (2024-01-24) ↗
Q1 FY24CQ3 2023Sep 30, 202351.0%-4.0 ptsResMed Q1 FY2024 Earnings Presentation (2023-10-26) ↗
Q4 FY23CQ2 2023Jun 30, 202354.0%+1.0 ptsResMed Q4 FY2023 Earnings Presentation (2023-08-03) ↗
Q3 FY23CQ1 2023Mar 31, 202355.0%–ResMed Q3 FY2023 Earnings Presentation (2023-04-27) ↗
Q2 FY23CQ4 2022Dec 31, 202253.0%–ResMed Q2 FY2023 Earnings Presentation (2023-01-26) ↗
Q1 FY23CQ3 2022Sep 30, 202255.0%–ResMed Q1 FY2023 Earnings Presentation (2022-10-27) ↗
Q4 FY22CQ2 2022Jun 30, 202253.0%–ResMed Q4 FY2022 Earnings Presentation (2022-08-11) ↗

Cite this data

StockData. (2026). ResMed Global Devices (%), quarterly Q4 FY22–Q3 FY26 [Data set]. Compiled from ResMed SEC filings and investor materials. https://stockdatahq.com/stocks/rmd/kpis/dev-global-mix-q

See every metric in the ResMed KPI table. Data updated Nov 8, 2026.

See a number that looks wrong?